These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2077145)

  • 21. Mexiletine and quinidine in ventricular ectopy.
    Fenster PE; Hanson CD
    Clin Pharmacol Ther; 1983 Aug; 34(2):136-42. PubMed ID: 6347497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of oral mexiletine in the prevention of exercise-induced ventricular ectopic activity.
    Koch G; Lindström B
    Eur J Clin Pharmacol; 1978 Jun; 13(4):237-40. PubMed ID: 352705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mexiletine in ventricular arrhythmias--an assessment by 24 hours holter monitoring.
    Gambhir DS; Khalilullah M; Bahl VK
    Indian Heart J; 1984; 36(3):142-6. PubMed ID: 6490043
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of ventricular arrhythmia with mexiletine (Mexitil), monitored by Holter ambulatory electrocardiography].
    Garimoldi M; Pirastu A; Barbanotti G; Sghirinzetti M; Catalano M; Castelfranco M
    Minerva Cardioangiol; 1988 Apr; 36(4):159-65. PubMed ID: 3173699
    [No Abstract]   [Full Text] [Related]  

  • 25. Mexiletine: long-term efficacy and hemodynamic actions in patients with ventricular arrhythmia.
    Sami M; Lisbona R
    Can J Cardiol; 1985; 1(4):251-8. PubMed ID: 2413974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of mexiletine in the medium-term treatment of ventricular arrhythmias. A randomized, double-blind, crossover trial against placebo in ambulatory patients.
    Masotti G; Morettini A; Casolo GC; Ieri A; Zipoli A; Serneri GG
    J Int Med Res; 1984; 12(2):73-80. PubMed ID: 6202571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the antiarrhythmic efficacy of mexiletine in patients with chronic ventricular arrhythmias.
    Van Durme JP
    Acta Cardiol Suppl; 1980; (25):121-5. PubMed ID: 6990664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mexiletine in the treatment of resistant ventricular arrhythmias: enhancement of efficacy and reduction of dose-related side effects by combination with quinidine.
    Duff HJ; Roden D; Primm RK; Oates JA; Woosley RL
    Circulation; 1983 May; 67(5):1124-8. PubMed ID: 6831673
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative efficacy and safety of oral mexiletine and quinidine in benign or potentially lethal ventricular arrhythmias.
    Morganroth J
    Am J Cardiol; 1987 Dec; 60(16):1276-81. PubMed ID: 3318368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of efficacy and tolerance of oral mexiletine by intravenous lidocaine application.
    Zehender M; Geibel A; Treese N; Hohnloser S; Meinertz T; Just H
    Clin Pharmacol Ther; 1988 Oct; 44(4):389-95. PubMed ID: 3168391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mexiletine in the treatment of ventricular arrhythmias.
    Henrard L; Carlier J
    Acta Cardiol Suppl; 1980; (25):127-35. PubMed ID: 6966452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pro-arrhythmic effects of antiarrhythmic drugs in patients with ischemic heart disease].
    Trusz-Gluza M; Smieja-Jaroczyńska B; Szymkowiak-Rzechorzek E; Buszman P; Dabrowski A; Kuśnierz B; Lada W; Luczak D; Mroczek-Czernecka D; Piotrowicz R
    Kardiol Pol; 1990; 33(5):328-34. PubMed ID: 2074629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mexiletine for ventricular arrhythmias.
    Podrid PJ; Lown B
    Am J Cardiol; 1981 Apr; 47(4):895-902. PubMed ID: 6782850
    [No Abstract]   [Full Text] [Related]  

  • 34. International Mexiletine and Placebo Antiarrhythmic Coronary Trial (IMPACT): II. Results from 24-hour electrocardiograms. IMPACT Research Group.
    Eur Heart J; 1986 Sep; 7(9):749-59. PubMed ID: 3533546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mexiletine in refractory ventricular arrhythmias.
    Fenster PE; Kern KB
    Clin Pharmacol Ther; 1983 Dec; 34(6):777-84. PubMed ID: 6641093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Combination of sotalol with the class I B substances mexiletine or tocainide in complex ventricular extrasystole].
    Wagner WL; Manz M; Lüderitz B
    Z Kardiol; 1987 May; 76(5):296-302. PubMed ID: 2441535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mexiletine for the treatment of ventricular arrhythmias associated with chronic obstructive pulmonary disease.
    Fracalossi C; Ziacchi V; Farisè F; Rossi A; Marino A; Lomanto B; Moretti L
    G Ital Cardiol; 1989 Jan; 19(1):46-52. PubMed ID: 2744314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of mexiletine in chronic ventricular arrhythmias compared with quinidine: a single-blind, randomized trial.
    Singh JB; Rasul AM; Shah A; Adams E; Flessas A; Kocot SL
    Am J Cardiol; 1984 Jan; 53(1):84-7. PubMed ID: 6362388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study to compare the efficacy, plasma concentration profile and tolerability of conventional mexiletine and slow-release mexiletine.
    Upward JW; Holt DW; Jackson G
    Eur Heart J; 1984 Mar; 5(3):247-52. PubMed ID: 6723694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative study of the antiarrhythmic efficacy of mexiletine and disopyramide in patients with chronic ventricular arrhythmias.
    Breithardt G; Seipel L; Lersmacher J; Abendroth RR
    J Cardiovasc Pharmacol; 1982; 4(2):276-84. PubMed ID: 6175812
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.